Results 51 to 60 of about 3,909 (222)

FIGO guideline on liver disease and pregnancy

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 170, Issue 1, Page 28-48, July 2025.
Abstract The number of women entering pregnancy with chronic liver disease is rising. Gestational liver disorders affect 3% of the pregnant population. Both can be associated with significant maternal and fetal morbidity and mortality. European guidance has recently been published to inform management.
Melanie Nana   +24 more
wiley   +1 more source

Short-term vasoactive agent treatment driven by physicians’ preference in acute esophageal variceal bleeding in a tertiary center [PDF]

open access: yesPeerJ, 2019
Background Vasoactive drugs are frequently used in combination with endoscopic variceal ligation (EVL) in treatment of acute esophageal variceal bleeding (EVB).
Yoen Young Chuah   +8 more
doaj   +2 more sources

A Case Study of Liver After Kidney Transplantation: Addressing Polycystic Diseases With Tailored Surgical and Postoperative Approaches

open access: yesClinical Case Reports, Volume 13, Issue 6, June 2025.
ABSTRACT Polycystic liver disease is a hereditary disease, which is characterized by the presence of multiple cysts within the liver. In this case, we report a patient with multiple cysts in the kidneys and liver, who underwent kidney transplantation in 2019 and then liver transplantation 4 years later.
Chengjun Sun   +4 more
wiley   +1 more source

The HYSTER study: the effect of intracervically administered terlipressin versus placebo on the number of gaseous emboli and fluid intravasation during hysteroscopic surgery: study protocol for a randomized controlled clinical trial

open access: yesTrials, 2018
Background Transcervical resection of myoma or endometrium is a safe, hysteroscopic, minimally invasive procedure. However, intravasation of distension fluid is a common phenomenon during these procedures.
Lucilla E. Overdijk   +5 more
doaj   +1 more source

Efficacy and safety of vasopressin and terlipressin in preterm neonates: a protocol for a systematic review

open access: yesBMJ Paediatrics Open, 2021
Background The use of vasoactive agents like arginine vasopressin (AVP) and terlipressin to treat hypotension or persistent pulmonary hypertension in critically ill preterm neonates is increasing.
Samira Samiee-Zafarghandy   +4 more
doaj   +1 more source

Pharmacotherapy for Cirrhosis in Japan

open access: yesPortal Hypertension &Cirrhosis, Volume 4, Issue 2, Page 111-119, June 2025.
As cirrhosis progresses from the compensated to the decompensated stage, liver disease‐related events such as varices, ascites, encephalopathy, sarcopenia, jaundice, and bleeding tendency, as well as liver carcinogenesis, can occur at a high rate. With the advent of new pharmacotherapies for cirrhosis in the last decade, liver fibrosis has been shown ...
Hiroki Nishikawa, Soo Ki Kim, Akira Asai
wiley   +1 more source

Effectiveness of Adjunctive Drug Therapy to Endoscopic Stenting in Liver Cirrhosis Complicated by Refractory Variceal Bleeding

open access: yesНеотложная медицинская помощь
AIM OF THE STUDY. Comparative clinical analysis of the efficacy of terlipressin and octreotide as additional drug therapy to mechanical hemostasis with nitinol stent in patients with liver cirrhosis complicated by bleeding from esophageal varices ...
A. Yu. Anisimov, Yu. A. Anisimov
doaj   +1 more source

Pregnancy Outcomes in Women With Liver Cirrhosis: A National Prospective Cohort Study Using the UK Obstetric Surveillance System

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, Volume 132, Issue 7, Page 935-943, June 2025.
ABSTRACT Objective Describe maternal/fetal outcomes of pregnant women with cirrhosis. Design Prospective, national cohort study utilising the UK Obstetric Surveillance System between 1st June 2017 and 30th November 2020. Setting UK. Population Pregnant women with cirrhosis.
Melanie Nana   +7 more
wiley   +1 more source

In vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V1 and V2

open access: yesJournal of Experimental Pharmacology, 2017
Khurram Jamil,1 Stephen Chris Pappas,2 Krishna R Devarakonda1 1Clinical Development, Mallinckrodt Pharmaceuticals, Bedminster, 2Orphan Therapeutics, LLC, Lebanon, NJ, USA Abstract: Terlipressin, a synthetic, systemic vasoconstrictor with selective ...
Jamil K, Pappas SC, Devarakonda KR
doaj  

Terlipressin for septic shock patients: a meta-analysis of randomized controlled study

open access: yesJournal of Intensive Care, 2019
Background Catecholamines are commonly used in septic shock but face limitations of their hypo-responsiveness and adverse events due to high dose. Terlipressin is a synthetic vasopressin analog with greater selectivity for the V1-receptor.
Yibing Zhu   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy